Latest Dstl Stories

LONDON, November 7, 2011 /PRNewswire/ -- Note: numbers in square brackets relate to - paragraphs in the Judgment. Harvey Boulter is available for interview. Investment fund manager Porton Group and the Ministry of Defence subsidiary Ploughshare Innovations* today won a court battle with 3M over the multi-national company's failure to promote a test for the "superbug" MRSA. The High Court in London found 3M was "in material breach of...

Experts from eight leading Department of Defense (DoD) organizations, the United Kingdom Defence Science and Technology Laboratory (U.K. DSTL) and industry partners completed an advanced laser and expendable countermeasure test Camp Atterbury Joint Maneuver Training Center. Providing oversight and expendable countermeasure and laser expertise, Naval Surface Warfare Center, Crane Division (NSWC Crane) partnered with Science Applications International, Corp. (SAIC) to provide logistics,...

OXFORD, England, Oct. 18 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced that the UK Intellectual Property Office (IPO) has rejected a revocation action brought by Biogene against three patents licensed exclusively to Enigma by the Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence. The patents cover electrically conducting polymer (ECP) thermal cycling technology which is used in...

Scientists are currently working on a new paint coating for military vehicles to essentially absorb a chemical warfare agent and then decontaminate itself. The paint is being developed by the UK's Defense Science and Technology Laboratory (DSTL) in hopes of providing protection for those operating in or around a vehicle after a chemical attack. The technology would be adapted from "strippable" coatings already being utilized to temporarily camouflage vehicles, BBC News...

TORONTO, Feb. 19 /PRNewswire/ - Defyrus Inc. today announced the signing an exclusive, worldwide license to a patent portfolio created by the United Kingdom's Defence Science and Technology Laboratory (Dstl) and licensed by Ploughshare Innovation Ltd, Dstl's commercialization company. These patents form the intellectual property foundation of the Company's vaccine product development programs. Defyrus and Ploughshare Innovation Ltd plan to expand their commercial interaction in 2009 to...

Advanced Life Sciences Holdings has announced that the UK's Defence Science and Technology Laboratory will evaluate the developmental compound ALS-886 as a treatment for chemically induced lung injury. ALS-886 is a small molecule therapeutic that, in preclinical studies, has demonstrated efficacy in reducing and preventing tissue damage in the lungs. Defence Science and Technology Laboratory (Dstl) will conduct animal efficacy studies to measure the ability of ALS-886 to improve the...

CHICAGO, July 17 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. , today announced that the United Kingdom's Defence Science and Technology Laboratory ("Dstl") will evaluate the developmental compound ALS-886 as a treatment for chemically induced lung injury. ALS-886 is a small molecule therapeutic that, in preclinical studies, has demonstrated efficacy in reducing and preventing tissue damage in the lungs. Dstl has experience modeling lung injury and will conduct animal...